PSYCH Symposium

📢 @Drug_Science and Prohibition Partners are excited to announce the return of PSYCH Symposium: London on Dec 4. Tickets on sale now. Stay tuned in the coming months for updates, speaker and panel announcements, and networking opportunities. psychsymposium.com

Year-in-review: 2025 saw Big Pharma enter psychedelics with AbbVie’s bretisilocin deal, late-stage wins at Compass, MindMed, Cybin and Beckley Psytech, policy progress in Germany, Czech and Australia, and new research data shaping access and regulation psychedelichealth.co.uk/2025/12/23/202…

Takeaways from PSYCH Symposium 2025, Part 2, looks beyond clinical data to what drives patient access, regulation, service models, investment, and system readiness. The shift is clear, progress now depends less on evidence alone and more on infrastructure. psychedelichealth.co.uk/2025/12/19/key…

📢 Excited to be the key media partner for PSYCH Symposium! 🧠 We're sharing key takeaways from their recent London. Opening remarks by Professor David Nutt (@Drug_Science) Fireside with Guy Goodwin (@Compasspathways) Keynote by Justin Smith-Ruiu psychedelichealth.co.uk/2025/12/15/hav…

Buzzing from an incredible day at @PSYCHSymposium. Amazing to bring together a community so passionate about advancing psychedelic medicine — the energy in the room truly reflected the momentum driving the field forward. Huge thanks to everyone who made it such a success ✨

Shortwave Life Sciences presents a study that examines psilocybin as a treatment for anorexia. The team develops a buccal film that avoids gut issues and aims to influence multiple neural pathways. Read more: psychedelichealth.co.uk/2025/12/04/sho…

We spoke with @COMPASSPathway CEO Kabir Nath on potentially being the first company to bring a classic psychedelic to market. -Mileposts until reaching the finish line. -Compass' influence in the psych space. -Lessons from Lykos' FDA rejection. psychedelichealth.co.uk/2025/12/02/com…

Tomorrow is the day 📅 PSYCH Symposium returns to London, Thu Dec 4 at Conway Hall. Thanks to Drug Science and sponsors Shortwave Life Sciences, Compass Pathways, FTI Consulting, Ambio Life Sciences, Prohibition Partners, Psychedelic Health, Grashaus Projects and Beautiful Space.

Shortwave Life Sciences will be a Gold Partner at the @PSYCHSymposium on 4 Dec 2025 at London’s Conway Hall. 🎉 Read more here: aquis.eu/stock-exchange… #PSY

5 VIP tickets remain for our December 4 conference. VIPs get networking lounge access, invite-only workshops, all-day catering, and a full day of panels, firesides, keynotes and industry networking across science, finance, healthcare and policy. 🎟️ psychsymposium.com/tickets

Shortwave Life Sciences’ feasibility study on psychedelic-assisted treatment for anorexia is among PSYCH Symposium’s most anticipated sessions. The 12:00 Thursday fireside covers study rationale, regulatory roadmap, and implications. 📅 Dec4 📍 London 🔗 psychsymposium.com

Thrilled to be speaking at @PSYCHSymposium on 4 December for a panel discussion on what Western science is missing as it embraces psychedelics. 👉 psychsymposium.com #psychedelics #veterans #ptsd

We announce the keynote for our December 4 event by Justin Smith Ruiu, Psychedelics and the Reality of Experience. He will present research from his 2025 book On Drugs, blending autobiography, intellectual history and philosophy on how psychedelics shape human thought.

Covid has faded from view, but its impact on frontline clinicians remains. A University of Washington trial found psilocybin therapy reduced depression in affected workers. Join us at PSYCH Symposium London 2025 to explore progress. Tickets 👉psychsymposium.com

Curious how our December 4 conference will feel? This recap from PSYCH Symposium 2023 shows why investors, researchers and stakeholders see it as a key place to connect. Watch youtube.com/watch?v=EGWpXU… 📅 Dec 4, 2025 Conway Hall, London

OCD affects around 1.2% of the UK population, with half of cases severe. Emerging research shows it may reduce OCD behaviours after one intake. Read more on OCD and psilocybin: psychedelichealth.co.uk/2025/10/30/psi…

We’re announcing the full agenda for PSYCH Symposium: London 2025, uniting global leaders in psychedelic-assisted therapy, mental health innovation, policy and investment. 📅 Dec 4, Conway Hall, London 🔗 psychsymposium.com/agenda #Psychedelics #MentalHealth #Innovation

Another sneak peek from our Dec 4 event: 5-MeO-DMT, the “God Molecule,” could be the next big story in psychedelics. Join @rosmcalpine , @Dr_Anne_Schlag , Patrick Cox, @tommaso_barba & @C_Agnorelli to explore its impact. 🔗 psychsymposium.com

Stay tuned! Our full agenda drops soon. A sneak peek at our opening fireside talk: Are We Ready? The Future of Psychedelic Medicine in Mainstream Healthcare with Prof. David Nutt & Dr. Guy Goodwin. 📅 Dec 4, 2025 | 📍 Conway Hall, London 🔗 psychsymposium.com

Friday, October 31 is the last day to get discount tickets for Europe's premiere conference on psychedelic medicine! 📅 Date: December 4, 2025 📍 Location: Conway Hall, London 🔗 More info & registration: psychsymposium.com